Literature DB >> 2078029

Synergistic drug combinations in AIDS therapy. Dipyridamole/3'-azido-3'-deoxythymidine in particular and principles of analysis in general.

J N Weinstein1, B Bunow, O S Weislow, R F Schinazi, S M Wahl, L M Wahl, J Szebeni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2078029     DOI： 10.1111/j.1749-6632.1990.tb17857.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  8 in total

1.  Potent and synergistic neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by hyperimmune anti-HIV immunoglobulin combined with monoclonal antibodies 2F5 and 2G12.

Authors:  J R Mascola; M K Louder; T C VanCott; C V Sapan; J S Lambert; L R Muenz; B Bunow; D L Birx; M L Robb
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  Ruxolitinib and tofacitinib are potent and selective inhibitors of HIV-1 replication and virus reactivation in vitro.

Authors:  Christina Gavegnano; Mervi Detorio; Catherine Montero; Alberto Bosque; Vicente Planelles; Raymond F Schinazi
Journal:  Antimicrob Agents Chemother       Date:  2014-01-13       Impact factor: 5.191

3.  Analysis of antimalarial synergy between bestatin and endoprotease inhibitors using statistical response-surface modelling.

Authors:  C S Gavigan; S G Machado; J P Dalton; A Bell
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

4.  Differential inhibition of 2'-deoxycytidine salvage as a possible mechanism for potentiation of the anti-human immunodeficiency virus activity of 2',3'-dideoxycytidine by dipyridamole.

Authors:  S S Patel; J Szebeni; L M Wahl; J N Weinstein
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

5.  In vitro inhibition of human immunodeficiency virus (HIV) type 1 replication by C2 symmetry-based HIV protease inhibitors as single agents or in combinations.

Authors:  S Kageyama; J N Weinstein; T Shirasaka; D J Kempf; D W Norbeck; J J Plattner; J Erickson; H Mitsuya
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

6.  Cellular pharmacology and potency of HIV-1 nucleoside analogs in primary human macrophages.

Authors:  Christina Gavegnano; Mervi A Detorio; Leda Bassit; Selwyn J Hurwitz; Thomas W North; Raymond F Schinazi
Journal:  Antimicrob Agents Chemother       Date:  2012-12-21       Impact factor: 5.191

7.  Effect of dipyridamole on zidovudine pharmacokinetics and short-term tolerance in asymptomatic human immunodeficiency virus-infected subjects.

Authors:  C W Hendrix; C Flexner; J Szebeni; S Kuwahara; S Pennypacker; J N Weinstein; P S Lietman
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

Review 8.  Role of the Synergistic Interactions of Environmental Pollutants in the Development of Cancer.

Authors:  Francisco Alejandro Lagunas-Rangel; Jenni Viivi Linnea-Niemi; Błażej Kudłak; Michael J Williams; Jörgen Jönsson; Helgi B Schiöth
Journal:  Geohealth       Date:  2022-04-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.